You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 59 No. 5, May 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Neurological Review
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Friedreich Ataxia

Effects of Genetic Understanding on Clinical Evaluation and Therapy

David R. Lynch, MD, PhD; Jennifer M. Farmer, MS; Laura J. Balcer, MD, MSCE; Robert B. Wilson, MD, PhD

Arch Neurol. 2002;59:743-747.

The discovery of the genetic cause of Friedreich ataxia has significantly affected our understanding of the disorder at both the clinical and basic science levels. Friedreich ataxia results from a deficiency of functional frataxin, a protein that appears to be involved in mitochondrial iron homeostasis. This leads to iron accumulation and mitochondrial abnormalities with consequent oxidant damage. The clinical spectrum of Friedreich ataxia has also expanded with the recognition of broader phenotypic features, including the absence of classical Friedreich ataxia features, later age at onset, and spasticity instead of ataxia. Although no proven therapy is yet available, antioxidants are a potential method for therapeutic intervention.


From the Departments of Neurology (Drs Lynch and Balcer), Pediatrics (Dr Lynch), Medicine (Ms Farmer), Ophthalmology (Dr Balcer), and Pathology and Lab Medicine (Dr Wilson), University of Pennsylvania School of Medicine, Philadelphia.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2002;59(5):878-880.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Speech perception ability in individuals with Friedreich ataxia
Rance et al.
Brain 2008;131:2002-2012.
ABSTRACT | FULL TEXT  

Myelopathy but normal MRI: where next?
Wong et al.
PN 2008;8:90-102.
ABSTRACT | FULL TEXT  

Presentation and Progression of Friedreich Ataxia and Implications for Physical Therapist Examination
Maring and Croarkin
ptjournal 2007;87:1687-1696.
ABSTRACT | FULL TEXT  

Measuring Friedreich ataxia: Complementary features of examination and performance measures
Lynch et al.
Neurology 2006;66:1711-1716.
ABSTRACT | FULL TEXT  

Rehabilitation Mnagement of Friedreich Ataxia: Lower Extremity Force-Control Variability and Gait Performance
Harris-Love et al.
Neurorehabil Neural Repair 2004;18:117-124.
ABSTRACT  

Late-Onset Tay-Sachs Disease as a Friedreich Ataxia Phenocopy
Perlman et al.
Arch Neurol 2002;59:1832-1832.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.